Mineralys Therapeutics, Inc. ($MLYS)
Karydas Daphne โ Director
Shares
3,000
Price
$0.00
Total Value
$0.00
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Karydas Daphne |
|---|---|
| Title | Director |
| Transaction Date | Mar 31, 2026 |
| Expiration Date | Sep 13, 2033 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Disposed |
| Security | Stock Option |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Apr 2, 2026 |
| Shares Purchased | 3,000 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 41,000 |
| Derivative | Derivative |
| Accession Number | 0001816952-26-000002 |
| Document | View SEC Filing |